Life after a GLP-1 · Part 7 of 12
Is there a GLP-1 maintenance dose, and does microdosing work?
The short answer
One trial has tested a lower maintenance dose. In SURMOUNT-MAINTAIN, people moved to 5 mg tirzepatide were 16.6% below their starting weight at week 112, on average, versus 21.9% on full dose and 9.9% on placebo. No trial has tested microdosing as people describe it online.1
Your prescriber decides about your medicine. Reviewed November 14, 2026.What people ask
Searched every month
- microdosing tirzepatide14,800
- microdosing ozempic4,400
- glp 1 maintenance dose590
US Google searches a month, 12-month average to November 2026 (Google Ads Keyword Planner).
What the research says
The numbers, on average
- 25%on 5 mg needed rescue medicine, vs 8% on full dose and 67% on placebo (378 people)1
- 44%of US adults using a GLP-1 changed how they took it; 28% skipped doses3
- 38%of those who changed how they took it named cost3
- Full dose
- −21.9%
- 5 mg
- −16.6%
- Placebo
- −9.9%
Spaced doses, small study
In a case series of 30 adults, people kept their dose but took it about every other week for 36 weeks on average. Weight went from 74.1 to 72.4 kg on average, with no comparison group.2
Search interest is shifting
Searches for microdosing tirzepatide fell from about 18,100 to 8,100 a month over the year, while searches for a GLP-1 maintenance dose rose from 390 to 880.
Labels set the approved doses
The Wegovy and Zepbound labels list the approved doses and schedules. Anything else is a prescriber decision.4
What it means for meals
Meals that do some of the work
Protein you can count
Aim for a clear protein source at each meal so the daily total adds up.
Whole grains over refined
Quinoa, barley and oats bring fiber that white bread and pasta lack.
Vegetables at lunch and dinner
Two servings a meal is an easy rule to keep.
Alma logs a meal from a photo, voice or text in about 10 seconds and shows protein and fiber for each meal.
Questions people ask
What does microdosing mean?
Online it usually means taking a smaller or less frequent dose than the label lists. No trial has tested it.
Is a lower maintenance dose an option?
One trial, SURMOUNT-MAINTAIN, tested it for tirzepatide. Whether it fits you is your prescriber’s decision.
Can I space out my doses to save money?
Talk to your prescriber first. A case series reported spaced dosing, but it had 30 people and no comparison group.
Sources
- SURMOUNT-MAINTAIN 2026. Full-dose vs lower-dose tirzepatide vs placebo for weight maintenance. PubMed.
- Wong et al. 2026. Reduced-frequency GLP-1 therapy after a weight plateau: a case series. Obesity.
- CDC. GLP-1 medicine use and changes in use among US adults. MMWR, 2026.
- FDA. Zepbound (tirzepatide) prescribing information, 2025.
- FDA. Wegovy (semaglutide) prescribing information, 2025.
- Aronne et al. 2024. Continued tirzepatide vs placebo for weight maintenance: the SURMOUNT-4 trial. JAMA.
US Google searches a month, 12-month average to November 2026 (Google Ads Keyword Planner). Editorial standards
Alma does not give medical advice. Starting, stopping or changing a GLP-1 dose is a decision for your prescriber.
